TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SOPH

SOPHiA GENETICS SA

Healthcare · Health Information Services

8.10$ +0.5% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

SOPHiA GENETICS SA (SOPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 198 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SOPH
Line item Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – 132 112 104 335 320 298 277 251 244 232 223 206 206 180 181 178 155 147 178 163 163 157 198
18 – – 110 91 80 301 283 260 235 208 196 182 169 153 148 125 126 117 99 90 117 103 99 96 137
18 – – 75 57 42 210 193 183 179 158 161 161 149 133 123 104 105 96 80 69 95 82 70 65 108
18 – – 97 78 64 281 265 244 217 189 179 162 149 133 123 104 105 96 80 69 95 82 70 65 108
– – – 7.9 7.4 7.5 7.9 7.1 6.3 6.6 6.4 8.1 10 9.8 9.8 15 11 9.9 9.8 8.7 11 9.5 8.5 17 14 14
– – – 3.4 3.1 3.7 4.5 5.7 5.0 5.8 5.8 5.2 4.1 5.5 5.2 6.5 6.0 6.5 6.5 5.9 5.1 6.2 6.7 6.4 7.1 7.1
– – – – 4.9 5.7 16 16 15 19 19 21 – 24 22 – – – – – – – – – – –
– – – 8.6 – – 8.3 8.3 – – – 8.2 – – – 9.0 – – – 8.3 30 34 – 9.6 36 –
– – – 4.7 13 14 14 7.4 17 18 18 12 21 23 24 18 26 27 30 21 30 34 35 26 – 36
-22 – – 32 30 33 45 45 46 49 45 44 47 52 47 55 48 60 64 59 61 101 103 116 111 115
– – – 22 21 25 28 29 30 31 28 27 29 32 29 36 30 29 31 27 29 34 37 51 47 51
– – – 3.9 2.6 1.0 1.4 1.8 1.9 2.0 2.3 2.7 3.0 3.5 2.9 2.9 2.7 2.6 2.5 2.2 2.3 2.5 2.6 2.7 2.7 2.7
– – – 1.3 5.8 6.2 8.8 2.3 7.8 7.4 5.6 2.2 7.7 6.6 6.0 2.3 6.2 5.3 5.9 1.9 4.6 7.7 6.1 5.3 13 12
– – – 0.5 – – – – – – – – – – – – – 13 13 13 13 47 48 48 48 48
22 – – 101 82 71 290 275 252 228 206 200 185 172 158 151 132 121 114 96 86 77 61 47 46 83
– – – -138 -150 -169 -190 -211 -237 -262 -285 -299 -319 -340 -354 -378 -391 -407 -425 -440 -458 -480 -500 -519 -539 -561
38 48 48 48 48 63 60 60 64 64 64 64 64 64 65 65 65 66 66 66 67 67 68 68 71 74

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?